Jul 14, 2023, 08:52 AM by

Startup, Endor Labs has been named a Gartner Cool Vendor in Platform Engineering for Scaling Application Security Practices, highlighting the company’s commitment to providing cutting-edge solutions that address the challenges faced by platform engineering and DevSecOps teams in meeting application security needs.

Jul 14, 2023, 08:52 AM by

Jul 14, 2023, 08:51 AM by

DoseMe, a leading provider of precision dosing software for therapeutic drug monitoring and creators of DoseMeRx and DoseMe Analytics, today announced the appointments of Paul Edwards to Chief Executive Officer, John Hardesky to the role of Chief Commercial Officer and Dr. Sharmeen Roy, PharmD, BCPS, to Chief Strategy and Science Officer.

Jul 14, 2023, 08:51 AM by

Jul 14, 2023, 01:00 AM by User Not Found

Bio-IT World | A panel of pharma representatives talked about their tech acquisition pipelines last month at the Bio-IT World Conference & Expo. Representatives from Roche, Janssen, and Novartis outlined their strategies for acquiring new technologies and the pitfalls they look for.

Jul 13, 2023, 09:59 AM by

Genedata Biologics supports R&D processes at innovative biopharmaceutical company developing breakthrough immunotherapies for the treatment of cancer and chronic inflammatory diseases

Jul 12, 2023, 10:45 AM by User Not Found

Bio-IT World | The European Commission announced this morning that it has fined Illumina and GRAIL approximately €432 million and €1,000 respectively—both record fines—for implementing their proposed merger before approval by the Commission, in breach of EU merger control rules.

Jul 12, 2023, 09:53 AM by

Skyelarke furthers its mission to break down barriers to clinical trial participation, with new SkyePay enhancements Cary, North Carolina- July 11th, 2023: Skyelarke, a health tech company, has announced some significant new additions to SkyePay, a cutting-edge patient payment technology built by and for the clinical research industry.

Jul 12, 2023, 09:53 AM by

Phastar's B Corp™ certification affirms its status as a 'force for good' organization International certification recognizes leading global specialist biometrics CRO’s commitment and leadership in corporate social responsibility and sustainable business practices.

Jul 12, 2023, 09:53 AM by

NCC Group, one of the world’s largest security consultancies with over 35 global offices, 2,000 employees in 12 countries and 14,000 clients, today appointed Siân John as Chief Technology Officer. Joining from Microsoft and with 25 years of cybersecurity experience across strategy, business risk, privacy, and technology, Siân will drive innovation, insights and intelligence at the firm through close interaction with clients, industry, and academia.

Jul 11, 2023, 09:32 AM by

New addition to comprehensive COB suite enables health plans to improve claim accuracy while reducing provider and member abrasion

Jul 11, 2023, 09:32 AM by

Jul 11, 2023, 01:00 AM by User Not Found

Bio-IT World | Federated storage systems were a hot topic at the Bio-IT World Conference & Expo in May. Susmit Shannigrahi, Assistant Professor at Tennessee Tech University, reported on Hydra, a federated model for genomics use cases funded by the National Science Foundation.

Jul 7, 2023, 08:42 AM by

Pharma Targeting, part of the The Targeting Group and a leading global pharmaceutical market intelligence and data company, has unveiled its latest pioneering initiative, designed to help pharma and biotech companies find the partners they need to get funded, noticed, and faster to market. The service uses data-driven intelligence to help customers identify and engage with the right partner, whether it be for licencing, in-licensing, funding, distribution, or any other business need.

Jul 6, 2023, 01:00 AM by User Not Found

Bio-IT World | Biomedical engineers at the University of Technology Sydney have collaborated with clinicians and cell specialists to develop the world’s first physiologically and clinically relevant disc-on-a-chip organ model that represents—they say—a breakthrough in low back pain studies.

Jun 29, 2023, 10:44 AM by

Mirikizumab is the first IL-23p19 targeted biologic to demonstrate efficacy for induction and maintenance therapy of moderately to severely active Ulcerative Colitis. Marketing authorisation was based on two randomised, double-blind, placebo-controlled phase 3 trials, LUCENT-1 and LUCENT-2. In both studies mirikizumab achieved primary and key secondary endpoints, including sustained clinical remission1 Decreases in bowel urgency severity were observed as early as week 2 in patients treated with mirikizumab versus placebo in LUCENT-11

Jun 29, 2023, 10:00 AM by

Cleveland Diagnostics has expanded to open a new facility to support the growing, nationwide demand for its prostate cancer test: IsoPSA. The new facility will be critical as the company continues to grow and develop additional tests for different types of cancers.

Jun 29, 2023, 10:00 AM by

Volume and Cost of Clinical Lab Tests Expected to Rise in 2023, Report Finds: Variety and complexity of routine and genetic testing poses challenge for health plans and clinicians

Jun 29, 2023, 01:00 AM by User Not Found

Bio-IT World | Illumina announces an AI algorithm that predicts disease-causing genetic mutations; American Gene Technologies’ new company will focus solely on advancing an HIV cure; Datacubed looks for genomic foundation for PTSD; and new partnerships for NTT Research, the National Cerebral and Cardiovascular Center, Seqera Labs, Genomics England, Complete Genomics. Plus, product updates from 10x Genomics, Thermo Fisher, Benchling, Saama Revvity, and more.

Jun 28, 2023, 01:00 AM by User Not Found

Bio-IT World | Legacy methods for developing a robust process and understanding process capability are limiting. Leveraging modern AI-based digital solutions throughout the product lifecycle provides expansive capability for creating more robust and capable processes.